Personalized Therapy Approach for Hospitalized Patients with Coronavirus Disease 2019.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 32649747.
- Also identified by DOI 10.1093/cid/ciaa964 and PMC identifier 7454444.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hospitalized patients with coronavirus disease 2019 (COVID-19) experiencing respiratory symptoms have different complications (inflammatory, co-infection, and thrombotic) that are identifiable by analytics patterns. Personalized treatment decisions decreased early mortality (odds ratio [OR] .144; 95% confidence interval [CI] .03-.686; P = .015). Increasing age (OR 1.06; P = .038) and therapeutic effort limitation (OR 9.684; P < .001) were associated with higher mortality.
Medical subject headings
- COVID-19